

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 4.63573043 |
| 2 | regulation of RNA export from nucleus (GO:0046831) | 4.20479558 |
| 3 | mitotic chromosome condensation (GO:0007076) | 4.10630138 |
| 4 | DNA unwinding involved in DNA replication (GO:0006268) | 4.06734090 |
| 5 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.90779730 |
| 6 | nuclear pore organization (GO:0006999) | 3.72509676 |
| 7 | DNA topological change (GO:0006265) | 3.67737738 |
| 8 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.63392533 |
| 9 | mRNA stabilization (GO:0048255) | 3.60850555 |
| 10 | RNA stabilization (GO:0043489) | 3.60850555 |
| 11 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.57055749 |
| 12 | formation of translation preinitiation complex (GO:0001731) | 3.56852570 |
| 13 | ribosome assembly (GO:0042255) | 3.53402674 |
| 14 | histone H2B ubiquitination (GO:0033523) | 3.51086492 |
| 15 | pore complex assembly (GO:0046931) | 3.48200621 |
| 16 | protein localization to endosome (GO:0036010) | 3.47319785 |
| 17 | regulation of translational fidelity (GO:0006450) | 3.43458945 |
| 18 | mitochondrial fusion (GO:0008053) | 3.40526152 |
| 19 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.32346647 |
| 20 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.31310578 |
| 21 | pentose-phosphate shunt (GO:0006098) | 3.29650481 |
| 22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.08603035 |
| 23 | establishment of integrated proviral latency (GO:0075713) | 3.08028735 |
| 24 | protein maturation by protein folding (GO:0022417) | 3.07164016 |
| 25 | response to peptidoglycan (GO:0032494) | 3.02523480 |
| 26 | protein localization to chromosome, centromeric region (GO:0071459) | 3.01203597 |
| 27 | ribosome biogenesis (GO:0042254) | 3.00113633 |
| 28 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.98722652 |
| 29 | nucleosome disassembly (GO:0006337) | 2.92842930 |
| 30 | protein-DNA complex disassembly (GO:0032986) | 2.92842930 |
| 31 | peptidyl-arginine N-methylation (GO:0035246) | 2.90920582 |
| 32 | peptidyl-arginine methylation (GO:0018216) | 2.90920582 |
| 33 | maturation of SSU-rRNA (GO:0030490) | 2.88344756 |
| 34 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 2.83733770 |
| 35 | mitotic metaphase plate congression (GO:0007080) | 2.83386073 |
| 36 | COPI coating of Golgi vesicle (GO:0048205) | 2.82851572 |
| 37 | Golgi transport vesicle coating (GO:0048200) | 2.82851572 |
| 38 | viral mRNA export from host cell nucleus (GO:0046784) | 2.82412676 |
| 39 | NADPH regeneration (GO:0006740) | 2.80840190 |
| 40 | NIK/NF-kappaB signaling (GO:0038061) | 2.79544685 |
| 41 | ribosomal small subunit biogenesis (GO:0042274) | 2.79040715 |
| 42 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.77949411 |
| 43 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.75387178 |
| 44 | pinocytosis (GO:0006907) | 2.74146804 |
| 45 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.69431144 |
| 46 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.69147320 |
| 47 | mitotic sister chromatid cohesion (GO:0007064) | 2.67561785 |
| 48 | establishment of viral latency (GO:0019043) | 2.60483599 |
| 49 | regulation of superoxide anion generation (GO:0032928) | 2.60179502 |
| 50 | regulation of translational termination (GO:0006449) | 2.59944887 |
| 51 | regulation of RIG-I signaling pathway (GO:0039535) | 2.58643888 |
| 52 | histone arginine methylation (GO:0034969) | 2.58643537 |
| 53 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57974620 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.57635669 |
| 55 | DNA replication initiation (GO:0006270) | 2.56785279 |
| 56 | corticosteroid receptor signaling pathway (GO:0031958) | 2.56056632 |
| 57 | protein complex localization (GO:0031503) | 2.55327565 |
| 58 | negative regulation of mRNA metabolic process (GO:1903312) | 2.53884185 |
| 59 | mRNA transcription (GO:0009299) | 2.53327738 |
| 60 | regulation of mRNA stability (GO:0043488) | 2.53162066 |
| 61 | heterochromatin organization (GO:0070828) | 2.52904764 |
| 62 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.52816815 |
| 63 | negative regulation of mRNA processing (GO:0050686) | 2.51864846 |
| 64 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.50652508 |
| 65 | DNA strand elongation (GO:0022616) | 2.49430412 |
| 66 | embryonic process involved in female pregnancy (GO:0060136) | 2.48444089 |
| 67 | negative regulation of histone methylation (GO:0031061) | 2.47366675 |
| 68 | regulation of RNA stability (GO:0043487) | 2.47166951 |
| 69 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.46951657 |
| 70 | glucose 6-phosphate metabolic process (GO:0051156) | 2.45061021 |
| 71 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.44801782 |
| 72 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 2.43874665 |
| 73 | sister chromatid segregation (GO:0000819) | 2.42923173 |
| 74 | dosage compensation (GO:0007549) | 2.40652225 |
| 75 | mitotic sister chromatid segregation (GO:0000070) | 2.40464341 |
| 76 | proline biosynthetic process (GO:0006561) | 2.39018173 |
| 77 | rRNA transcription (GO:0009303) | 2.38840624 |
| 78 | response to muramyl dipeptide (GO:0032495) | 2.38260806 |
| 79 | glucose catabolic process (GO:0006007) | 2.37709676 |
| 80 | regulation of histone H3-K9 methylation (GO:0051570) | 2.35969268 |
| 81 | chromosome condensation (GO:0030261) | 2.35613891 |
| 82 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.34816659 |
| 83 | DNA duplex unwinding (GO:0032508) | 2.34795312 |
| 84 | regulation of histone H3-K27 methylation (GO:0061085) | 2.34299796 |
| 85 | protein export from nucleus (GO:0006611) | 2.34019202 |
| 86 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.34009577 |
| 87 | mRNA splicing, via spliceosome (GO:0000398) | 2.34009577 |
| 88 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.33035339 |
| 89 | cellular protein complex localization (GO:0034629) | 2.32540347 |
| 90 | chromatin assembly (GO:0031497) | 2.30485104 |
| 91 | IMP metabolic process (GO:0046040) | 2.29456358 |
| 92 | establishment of chromosome localization (GO:0051303) | 2.28695357 |
| 93 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.28387023 |
| 94 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.27619388 |
| 95 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.27549794 |
| 96 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.27206407 |
| 97 | RNA splicing, via transesterification reactions (GO:0000375) | 2.26886722 |
| 98 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.26275089 |
| 99 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.26275089 |
| 100 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.25872342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.10909919 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.58745078 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.49579911 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.40148119 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.11566725 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.04292536 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.91748766 |
| 8 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.50414359 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.36288768 |
| 10 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.24692963 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14423257 |
| 12 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.14056668 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.11730230 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.09585677 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.04710276 |
| 16 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94832127 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.94614924 |
| 18 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94084469 |
| 19 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.85222921 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.82512395 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80086675 |
| 22 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.76246199 |
| 23 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.76179431 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.74335161 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.72407003 |
| 26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71689443 |
| 27 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.68062200 |
| 28 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65764600 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58992356 |
| 30 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.54483726 |
| 31 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.54355299 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.51965621 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51200812 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50532400 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.50020188 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49742221 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.47335075 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.45829725 |
| 39 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.43273152 |
| 40 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.42866873 |
| 41 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.42225732 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.41395779 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.41376387 |
| 44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.41179193 |
| 45 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40875972 |
| 46 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.40477272 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40436213 |
| 48 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37783052 |
| 49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35717139 |
| 50 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.34439226 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33000130 |
| 52 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.29456139 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29221072 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28932863 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28253561 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27574987 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25749400 |
| 58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25694849 |
| 59 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.25472477 |
| 60 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25447916 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25307687 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23614144 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23061662 |
| 64 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.22228564 |
| 65 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.21925666 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21347445 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21340848 |
| 68 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21121072 |
| 69 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20953863 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20194930 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19591518 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19579219 |
| 73 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.19236612 |
| 74 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.18782030 |
| 75 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.18709022 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17841397 |
| 77 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16603206 |
| 78 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.14978134 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14011899 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13743722 |
| 81 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.13313323 |
| 82 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12267369 |
| 83 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12215926 |
| 84 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.12167630 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10893296 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10312437 |
| 87 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09565732 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.09553643 |
| 89 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09089179 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08665443 |
| 91 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08300876 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.08128080 |
| 93 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03956650 |
| 94 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03838675 |
| 95 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.02089192 |
| 96 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01369034 |
| 97 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.00901712 |
| 98 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00120259 |
| 99 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00111958 |
| 100 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.00083620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 3.68008688 |
| 2 | MP0005451_abnormal_body_composition | 3.18978451 |
| 3 | MP0003303_peritoneal_inflammation | 3.06721698 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.99150600 |
| 5 | MP0003693_abnormal_embryo_hatching | 2.85430779 |
| 6 | MP0003111_abnormal_nucleus_morphology | 2.67537554 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 2.55574419 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.44447787 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.39196418 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.17845035 |
| 11 | MP0003077_abnormal_cell_cycle | 2.17179619 |
| 12 | MP0003221_abnormal_cardiomyocyte_apopto | 2.12923147 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.10561372 |
| 14 | MP0001730_embryonic_growth_arrest | 2.03421333 |
| 15 | MP0009278_abnormal_bone_marrow | 1.93574599 |
| 16 | MP0004510_myositis | 1.90323198 |
| 17 | MP0004233_abnormal_muscle_weight | 1.89547904 |
| 18 | MP0008260_abnormal_autophagy | 1.87036165 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 1.78669001 |
| 20 | MP0000747_muscle_weakness | 1.76736045 |
| 21 | MP0002396_abnormal_hematopoietic_system | 1.76368711 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.75482713 |
| 23 | MP0000537_abnormal_urethra_morphology | 1.67292741 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.66394464 |
| 25 | MP0003436_decreased_susceptibility_to | 1.58618082 |
| 26 | MP0000350_abnormal_cell_proliferation | 1.56987426 |
| 27 | MP0000858_altered_metastatic_potential | 1.54964674 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.43442007 |
| 29 | MP0002009_preneoplasia | 1.42514377 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 1.42228739 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.42127679 |
| 32 | MP0010307_abnormal_tumor_latency | 1.42085406 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.39490661 |
| 34 | MP0000313_abnormal_cell_death | 1.39201688 |
| 35 | MP0009672_abnormal_birth_weight | 1.38950140 |
| 36 | MP0002080_prenatal_lethality | 1.38222881 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.37249939 |
| 38 | MP0008932_abnormal_embryonic_tissue | 1.36173074 |
| 39 | MP0009840_abnormal_foam_cell | 1.35713027 |
| 40 | MP0000490_abnormal_crypts_of | 1.35025107 |
| 41 | MP0000750_abnormal_muscle_regeneration | 1.34240139 |
| 42 | MP0001727_abnormal_embryo_implantation | 1.32797888 |
| 43 | MP0008058_abnormal_DNA_repair | 1.30085938 |
| 44 | MP0002796_impaired_skin_barrier | 1.29233102 |
| 45 | MP0003315_abnormal_perineum_morphology | 1.28369688 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.27923568 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.27923568 |
| 48 | MP0005501_abnormal_skin_physiology | 1.25628359 |
| 49 | MP0008007_abnormal_cellular_replicative | 1.23739488 |
| 50 | MP0004947_skin_inflammation | 1.23616459 |
| 51 | MP0001672_abnormal_embryogenesis/_devel | 1.23589939 |
| 52 | MP0005380_embryogenesis_phenotype | 1.23589939 |
| 53 | MP0002419_abnormal_innate_immunity | 1.21925314 |
| 54 | MP0003984_embryonic_growth_retardation | 1.21127198 |
| 55 | MP0002398_abnormal_bone_marrow | 1.18672890 |
| 56 | MP0008438_abnormal_cutaneous_collagen | 1.16275665 |
| 57 | MP0005000_abnormal_immune_tolerance | 1.15934479 |
| 58 | MP0000358_abnormal_cell_content/ | 1.14368367 |
| 59 | MP0003448_altered_tumor_morphology | 1.13690964 |
| 60 | MP0002088_abnormal_embryonic_growth/wei | 1.13516858 |
| 61 | MP0002086_abnormal_extraembryonic_tissu | 1.12562003 |
| 62 | MP0000685_abnormal_immune_system | 1.11747741 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.11065558 |
| 64 | MP0003091_abnormal_cell_migration | 1.10910992 |
| 65 | MP0001849_ear_inflammation | 1.10375779 |
| 66 | MP0001697_abnormal_embryo_size | 1.10110137 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.08053219 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.07037106 |
| 69 | MP0005621_abnormal_cell_physiology | 1.02315415 |
| 70 | MP0004087_abnormal_muscle_fiber | 1.01868699 |
| 71 | MP0002429_abnormal_blood_cell | 1.01626189 |
| 72 | MP0002019_abnormal_tumor_incidence | 1.00909094 |
| 73 | MP0002332_abnormal_exercise_endurance | 1.00706313 |
| 74 | MP0005384_cellular_phenotype | 1.00567983 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 1.00381086 |
| 76 | MP0002148_abnormal_hypersensitivity_rea | 1.00247028 |
| 77 | MP0005025_abnormal_response_to | 0.99538422 |
| 78 | MP0002722_abnormal_immune_system | 0.99135479 |
| 79 | MP0000733_abnormal_muscle_development | 0.99121672 |
| 80 | MP0003828_pulmonary_edema | 0.98978814 |
| 81 | MP0002420_abnormal_adaptive_immunity | 0.98281344 |
| 82 | MP0001819_abnormal_immune_cell | 0.96588053 |
| 83 | MP0005666_abnormal_adipose_tissue | 0.94815827 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.93255808 |
| 85 | MP0010630_abnormal_cardiac_muscle | 0.93090918 |
| 86 | MP0001790_abnormal_immune_system | 0.92654162 |
| 87 | MP0005387_immune_system_phenotype | 0.92654162 |
| 88 | MP0002269_muscular_atrophy | 0.92592759 |
| 89 | MP0000703_abnormal_thymus_morphology | 0.92553290 |
| 90 | MP0009785_altered_susceptibility_to | 0.91728714 |
| 91 | MP0002723_abnormal_immune_serum | 0.91347817 |
| 92 | MP0000716_abnormal_immune_system | 0.90297863 |
| 93 | MP0001881_abnormal_mammary_gland | 0.89398898 |
| 94 | MP0001800_abnormal_humoral_immune | 0.87874984 |
| 95 | MP0000689_abnormal_spleen_morphology | 0.87872173 |
| 96 | MP0004272_abnormal_basement_membrane | 0.87026662 |
| 97 | MP0004197_abnormal_fetal_growth/weight/ | 0.85713533 |
| 98 | MP0001853_heart_inflammation | 0.84214283 |
| 99 | MP0000751_myopathy | 0.84017292 |
| 100 | MP0008057_abnormal_DNA_replication | 0.83737677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperacusis (HP:0010780) | 3.63057559 |
| 2 | Progressive muscle weakness (HP:0003323) | 3.49635607 |
| 3 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.40427033 |
| 4 | Insomnia (HP:0100785) | 3.04888773 |
| 5 | Increased connective tissue (HP:0009025) | 2.94274845 |
| 6 | Achilles tendon contracture (HP:0001771) | 2.87804242 |
| 7 | Pelvic girdle muscle weakness (HP:0003749) | 2.86806711 |
| 8 | Shoulder girdle muscle weakness (HP:0003547) | 2.82055000 |
| 9 | Fatigue (HP:0012378) | 2.66163150 |
| 10 | Abnormal gallbladder physiology (HP:0012438) | 2.61500987 |
| 11 | Cholecystitis (HP:0001082) | 2.61500987 |
| 12 | Spastic diplegia (HP:0001264) | 2.58305882 |
| 13 | Distal lower limb amyotrophy (HP:0008944) | 2.56460129 |
| 14 | Ragged-red muscle fibers (HP:0003200) | 2.53021351 |
| 15 | Difficulty climbing stairs (HP:0003551) | 2.50912925 |
| 16 | Nemaline bodies (HP:0003798) | 2.48384233 |
| 17 | Multiple enchondromatosis (HP:0005701) | 2.48082941 |
| 18 | Cellulitis (HP:0100658) | 2.44919441 |
| 19 | Abnormality of the Achilles tendon (HP:0005109) | 2.43395281 |
| 20 | Calcaneovalgus deformity (HP:0001848) | 2.41297879 |
| 21 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.38513425 |
| 22 | Progressive external ophthalmoplegia (HP:0000590) | 2.35675890 |
| 23 | Overriding aorta (HP:0002623) | 2.35357707 |
| 24 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.30691573 |
| 25 | Abnormality of the calcaneus (HP:0008364) | 2.29457663 |
| 26 | Muscle fiber inclusion bodies (HP:0100299) | 2.26952432 |
| 27 | Thrombocytosis (HP:0001894) | 2.25498988 |
| 28 | Insidious onset (HP:0003587) | 2.23770541 |
| 29 | Termporal pattern (HP:0011008) | 2.23770541 |
| 30 | Trismus (HP:0000211) | 2.19429219 |
| 31 | Orthostatic hypotension (HP:0001278) | 2.15419192 |
| 32 | Upper limb muscle weakness (HP:0003484) | 2.14140269 |
| 33 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.11710573 |
| 34 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.11710573 |
| 35 | Sparse lateral eyebrow (HP:0005338) | 2.08996585 |
| 36 | Reticulocytosis (HP:0001923) | 2.08379422 |
| 37 | Elfin facies (HP:0004428) | 2.07240919 |
| 38 | Aplastic anemia (HP:0001915) | 2.06977123 |
| 39 | Increased variability in muscle fiber diameter (HP:0003557) | 2.06966812 |
| 40 | Distal lower limb muscle weakness (HP:0009053) | 2.06536788 |
| 41 | Breech presentation (HP:0001623) | 1.99508910 |
| 42 | Nonimmune hydrops fetalis (HP:0001790) | 1.98955631 |
| 43 | Microvesicular hepatic steatosis (HP:0001414) | 1.98437257 |
| 44 | Deformed tarsal bones (HP:0008119) | 1.98384407 |
| 45 | Dysmetric saccades (HP:0000641) | 1.95224574 |
| 46 | Abnormality of macrophages (HP:0004311) | 1.94909947 |
| 47 | Abnormality of reticulocytes (HP:0004312) | 1.93077551 |
| 48 | Premature rupture of membranes (HP:0001788) | 1.90844968 |
| 49 | Myopathic facies (HP:0002058) | 1.90187551 |
| 50 | Ulnar bowing (HP:0003031) | 1.89850720 |
| 51 | Hypertensive crisis (HP:0100735) | 1.86140807 |
| 52 | Back pain (HP:0003418) | 1.85721899 |
| 53 | Type 1 muscle fiber predominance (HP:0003803) | 1.85569869 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 1.83115483 |
| 55 | Vertebral compression fractures (HP:0002953) | 1.83104810 |
| 56 | Recurrent viral infections (HP:0004429) | 1.82647757 |
| 57 | Myocardial infarction (HP:0001658) | 1.81726032 |
| 58 | Recurrent abscess formation (HP:0002722) | 1.79349203 |
| 59 | Exercise-induced myalgia (HP:0003738) | 1.79216052 |
| 60 | Cortical dysplasia (HP:0002539) | 1.77197325 |
| 61 | Deep palmar crease (HP:0006191) | 1.75831374 |
| 62 | Eczematoid dermatitis (HP:0000976) | 1.75179533 |
| 63 | Distal arthrogryposis (HP:0005684) | 1.73281263 |
| 64 | Lower limb amyotrophy (HP:0007210) | 1.73171762 |
| 65 | Rough bone trabeculation (HP:0100670) | 1.72297837 |
| 66 | Patellar dislocation (HP:0002999) | 1.69799342 |
| 67 | Polycythemia (HP:0001901) | 1.69562428 |
| 68 | IgM deficiency (HP:0002850) | 1.69146238 |
| 69 | Long palpebral fissure (HP:0000637) | 1.68646316 |
| 70 | Increased nuchal translucency (HP:0010880) | 1.68120516 |
| 71 | Abnormality of glycolipid metabolism (HP:0010969) | 1.66914712 |
| 72 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.66914712 |
| 73 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.66914712 |
| 74 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.66814148 |
| 75 | Recurrent bacterial skin infections (HP:0005406) | 1.66577046 |
| 76 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.66231598 |
| 77 | Abnormality of the peritoneum (HP:0002585) | 1.65730012 |
| 78 | Renal duplication (HP:0000075) | 1.65470030 |
| 79 | Flat cornea (HP:0007720) | 1.65300755 |
| 80 | Bulbar palsy (HP:0001283) | 1.64960198 |
| 81 | Asymmetry of the thorax (HP:0001555) | 1.64641096 |
| 82 | Disproportionate tall stature (HP:0001519) | 1.64133424 |
| 83 | Syringomyelia (HP:0003396) | 1.63690430 |
| 84 | Spinal cord lesions (HP:0100561) | 1.63690430 |
| 85 | Limb-girdle muscle atrophy (HP:0003797) | 1.62137725 |
| 86 | Deviation of the thumb (HP:0009603) | 1.62069879 |
| 87 | Reticulocytopenia (HP:0001896) | 1.60773601 |
| 88 | Petechiae (HP:0000967) | 1.59200982 |
| 89 | Apathy (HP:0000741) | 1.59095283 |
| 90 | Hammertoe (HP:0001765) | 1.58576046 |
| 91 | Round ear (HP:0100830) | 1.57798585 |
| 92 | Decreased motor nerve conduction velocity (HP:0003431) | 1.55158284 |
| 93 | Obstructive lung disease (HP:0006536) | 1.54617408 |
| 94 | Chronic obstructive pulmonary disease (HP:0006510) | 1.54617408 |
| 95 | Diminished motivation (HP:0000745) | 1.53726193 |
| 96 | Progressive hearing impairment (HP:0001730) | 1.53049983 |
| 97 | Protrusio acetabuli (HP:0003179) | 1.53029574 |
| 98 | EMG: myopathic abnormalities (HP:0003458) | 1.52202660 |
| 99 | Deep philtrum (HP:0002002) | 1.51398530 |
| 100 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.51358373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.68193539 |
| 2 | IRAK3 | 3.55047460 |
| 3 | TRIB3 | 3.22047926 |
| 4 | NME2 | 2.81829660 |
| 5 | SMG1 | 2.76947417 |
| 6 | ICK | 2.36081582 |
| 7 | PRPF4B | 2.35364770 |
| 8 | EEF2K | 2.15140170 |
| 9 | SRPK1 | 1.99321459 |
| 10 | TAOK2 | 1.99039123 |
| 11 | LATS2 | 1.95073463 |
| 12 | MAP3K10 | 1.90179915 |
| 13 | MAP3K14 | 1.88090048 |
| 14 | TSSK6 | 1.84491905 |
| 15 | SCYL2 | 1.80631112 |
| 16 | MAP2K3 | 1.67211567 |
| 17 | CDC7 | 1.63089678 |
| 18 | ALK | 1.53500268 |
| 19 | MAP3K11 | 1.52590689 |
| 20 | MOS | 1.49791756 |
| 21 | PKN2 | 1.42175248 |
| 22 | MAP3K13 | 1.30522101 |
| 23 | TTN | 1.29975733 |
| 24 | IRAK4 | 1.27959475 |
| 25 | ARAF | 1.26444840 |
| 26 | RIPK4 | 1.24392384 |
| 27 | BUB1 | 1.23945774 |
| 28 | BRD4 | 1.23068984 |
| 29 | TESK2 | 1.22063852 |
| 30 | MAP3K8 | 1.20142787 |
| 31 | CDK4 | 1.14629269 |
| 32 | CDK7 | 1.14037192 |
| 33 | LATS1 | 1.14010525 |
| 34 | PAK4 | 1.13768716 |
| 35 | TTK | 1.10801132 |
| 36 | NTRK1 | 1.04140302 |
| 37 | TAOK1 | 1.02378883 |
| 38 | ERN1 | 1.01831718 |
| 39 | RPS6KB2 | 1.00435315 |
| 40 | SIK1 | 0.98680243 |
| 41 | MAP3K12 | 0.96419175 |
| 42 | MATK | 0.94810851 |
| 43 | MAP3K1 | 0.93446710 |
| 44 | AURKA | 0.90532406 |
| 45 | TBK1 | 0.89359743 |
| 46 | ILK | 0.89062706 |
| 47 | MAP3K9 | 0.85226702 |
| 48 | KDR | 0.80769461 |
| 49 | MTOR | 0.80493237 |
| 50 | NEK9 | 0.80229459 |
| 51 | CHEK2 | 0.80223311 |
| 52 | RPS6KA4 | 0.79404865 |
| 53 | BRAF | 0.78627687 |
| 54 | PDGFRA | 0.78337043 |
| 55 | FES | 0.77558668 |
| 56 | CSK | 0.76870951 |
| 57 | PBK | 0.75871127 |
| 58 | MAP4K1 | 0.75618915 |
| 59 | JAK3 | 0.75055457 |
| 60 | CDK6 | 0.74586909 |
| 61 | RIPK1 | 0.73951742 |
| 62 | PIM2 | 0.73802262 |
| 63 | MAP2K4 | 0.71654834 |
| 64 | PTK6 | 0.71124262 |
| 65 | NEK2 | 0.71057982 |
| 66 | STK10 | 0.70631334 |
| 67 | EIF2AK3 | 0.70294631 |
| 68 | CHEK1 | 0.66370058 |
| 69 | BMX | 0.64707354 |
| 70 | VRK2 | 0.64076802 |
| 71 | MAP3K5 | 0.61797890 |
| 72 | KSR2 | 0.61757512 |
| 73 | FGFR4 | 0.60524140 |
| 74 | NEK1 | 0.60403495 |
| 75 | CDK9 | 0.59852643 |
| 76 | PLK4 | 0.56523222 |
| 77 | AURKB | 0.55047673 |
| 78 | AKT2 | 0.54345476 |
| 79 | PAK2 | 0.53507078 |
| 80 | FGR | 0.52274081 |
| 81 | ATR | 0.51044925 |
| 82 | CLK1 | 0.50385788 |
| 83 | RET | 0.49477838 |
| 84 | STK4 | 0.49472350 |
| 85 | IRAK2 | 0.47039374 |
| 86 | MAP2K2 | 0.46231878 |
| 87 | STK24 | 0.45787986 |
| 88 | CSF1R | 0.44988282 |
| 89 | VRK1 | 0.44315793 |
| 90 | BLK | 0.42910576 |
| 91 | MAP2K7 | 0.41341886 |
| 92 | LRRK2 | 0.41248506 |
| 93 | CDK2 | 0.40736309 |
| 94 | PIM1 | 0.40278559 |
| 95 | MAP3K3 | 0.39551465 |
| 96 | CDK1 | 0.39079112 |
| 97 | EPHB1 | 0.38886496 |
| 98 | PDPK1 | 0.37646267 |
| 99 | PASK | 0.37581350 |
| 100 | KSR1 | 0.37450901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.42198499 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.25351313 |
| 3 | Spliceosome_Homo sapiens_hsa03040 | 2.25300712 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.93302476 |
| 5 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.75928182 |
| 6 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.73148402 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.72722182 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.72075652 |
| 9 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.60133105 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54063217 |
| 11 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.50410403 |
| 12 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.49432799 |
| 13 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.49389741 |
| 14 | Thyroid cancer_Homo sapiens_hsa05216 | 1.48635945 |
| 15 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.46534246 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.44691736 |
| 17 | Apoptosis_Homo sapiens_hsa04210 | 1.44372244 |
| 18 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.41983543 |
| 19 | Cell cycle_Homo sapiens_hsa04110 | 1.41600122 |
| 20 | RNA transport_Homo sapiens_hsa03013 | 1.41041590 |
| 21 | Bladder cancer_Homo sapiens_hsa05219 | 1.38247096 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37012701 |
| 23 | Prion diseases_Homo sapiens_hsa05020 | 1.34370043 |
| 24 | Shigellosis_Homo sapiens_hsa05131 | 1.33826368 |
| 25 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.33524885 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32352059 |
| 27 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.31031601 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29960487 |
| 29 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.27842656 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.26523363 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23376417 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.21225029 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.20901182 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18425364 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16790163 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15464524 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.14140359 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.13678983 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.08796406 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08237413 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07868593 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06487792 |
| 43 | Base excision repair_Homo sapiens_hsa03410 | 1.06234289 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.03671147 |
| 45 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02284996 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01529343 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00260929 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00005414 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99907928 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97984917 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96802442 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.96301109 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95564517 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95483078 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94959096 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94786533 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93614270 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.92547053 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91589560 |
| 60 | Alcoholism_Homo sapiens_hsa05034 | 0.90897795 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88452871 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.88179500 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87071864 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86838876 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83549414 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82696754 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82406012 |
| 68 | * Ribosome_Homo sapiens_hsa03010 | 0.81189990 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80383492 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.79960540 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76977539 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75361042 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74491578 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73443337 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.73033314 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72794382 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72415277 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71866666 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70620382 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.68663945 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.67184825 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.66988924 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66833125 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66264667 |
| 85 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.64643835 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64500973 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62097111 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.61836049 |
| 89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.61587128 |
| 90 | Allograft rejection_Homo sapiens_hsa05330 | 0.59804168 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58877157 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56718938 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55720471 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.55128582 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.52283455 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.51483362 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51461164 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49893602 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49540237 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.48782772 |

